• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Canada Goose Holdings Inc. Subordinate Voting Shares

    2/14/24 3:55:44 PM ET
    $GOOS
    Apparel
    Consumer Discretionary
    Get the next $GOOS alert in real time by email
    SC 13G 1 goos_21424.htm PATIENT CAPITAL MANAGEMENT, LLC goos_21424.htm
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    CANADA GOOSE HOLDINGS INC
    (Name of Issuer)
    Subordinated Shares
    (Title of Class of Securities)
    135086106
    (CUSIP Number)
    December 29, 2023
    (Date of Event which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    [X] Rule 13d-1(b)
    [   ] Rule 13d-1(c)
    [   ] Rule 13d-1(d)
    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see Instructions).
    CUSIP No.: 135086106
           
    1
    NAME OF REPORTING PERSON
    Patient Capital Management, LLC
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    84-4277115
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) [   ]
    (b) [   ]
    3 SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5
    SOLE VOTING POWER
    3,842,824
    6
    SHARED VOTING POWER
    7
    SOLE DISPOSITIVE POWER
    3,842,824
    8
    SHARED DISPOSITIVE POWER
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    3,842,824
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    [   ]
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    8.14%
    12
    TYPE OF REPORTING PERSON
    IA
    CUSIP No.: 135086106
           
    1
    NAME OF REPORTING PERSON
    Patient Opportunity Trust, a series of Advisor Managed Portfolios
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    52-2203385
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) [   ]
    (b) [   ]
    3 SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5
    SOLE VOTING POWER
    6
    SHARED VOTING POWER
    3,000,000
    7
    SOLE DISPOSITIVE POWER
    8
    SHARED DISPOSITIVE POWER
    3,000,000
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    3,000,000 (this amount is also included in the aggregate amount reported by Patient Capital Management, LLC)
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    [   ]
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    6.35%
    12
    TYPE OF REPORTING PERSON
    IV
    CUSIP No.: 135086106
    ITEM 1(a). NAME OF ISSUER:
    CANADA GOOSE HOLDINGS INC
    ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
    250 Bowie Ave

    Toronto, Ontario, Canada
    ITEM 2(a). NAME OF PERSON FILING:
    Patient Capital Management, LLC
    Patient Opportunity Trust, a series of Advisor Managed Portfolios
    ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
    One South Street, Suite 2550
    Baltimore, MD 21202
    ITEM 2(c). CITIZENSHIP:
    Delaware
    Delaware
    ITEM 2(d). TITLE OF CLASS OF SECURITIES:
    Subordinated Shares
    ITEM 2(e). CUSIP NUMBER:
    135086106
    ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A:
    (a)
    [ ]
    Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c);
    (b)
    [ ]
    Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)
    [ ]
    Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)
    [X]
    Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
    (e)
    [X]
    An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
    (f)
    [ ]
    An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
    (g)
    [ ]
    A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
    (h)
    [ ]
    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)
    [ ]
    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)
    [ ]
    A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);
    (k)
    [ ]
    Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution:
    ITEM 4. OWNERSHIP
    (a) Amount beneficially owned:
    1) Patient Capital Management, LLC is deemed to be the beneficial owner of 3,842,824 shares of common stock.

    2) Patient Opportunity Trust is deemed to be beneficial owner of 3,000,000 shares of common stock.
    (b) Percent of class:
    1) Patient Capital Management, LLC - 8.14%

    2) Patient Opportunity Trust - 6.35%
    (c) Number of shares as to which the person has:
    (i) sole power to vote or to direct the vote:
    Patient Capital Management, LLC : 3,842,824

    Patient Opportunity Trust, a series of Advisor Managed Portfolios :
    (ii) shared power to vote or to direct the vote:
    Patient Capital Management, LLC :

    Patient Opportunity Trust, a series of Advisor Managed Portfolios : 3,000,000
    (iii) sole power to dispose or direct the disposition of:
    Patient Capital Management, LLC : 3,842,824

    Patient Opportunity Trust, a series of Advisor Managed Portfolios :
    (iv) shared power to dispose or to direct the disposition of:
    Patient Capital Management, LLC :

    Patient Opportunity Trust, a series of Advisor Managed Portfolios : 3,000,000
    ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].
    ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
    Various accounts managed by Patient Capital Management, LLC have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities. The interest of one account, Patient Opportunity Trust, a series of Advisor Managed Portfolios, an investment company registered under the Investment Company Act of 1940 and managed by Patient Capital Management, LLC was deemed to be the beneficial owner of 3,000,000 shares or 6.35% of the total shares outstanding as of December 29, 2023.
    ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
    See Exhibit A
    ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
    N/A
    ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
    N/A
    ITEM 10. CERTIFICATION:
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
    CUSIP No.: 135086106
    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    February 14 2024
    Patient Capital Management, LLC
    By:
    /s/ Milton Dodge
    Name:
    Milton Dodge
    Title:
    Chief Compliance Officer
    February 14 2024
    By:
    /s/ Russell B. Simon
    Name:
    Russell B. Simon
    Title:
    CFO/Treasurer
    Attention — Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).
    CUSIP No.: 135086106
    Exhibit A

    Joint Filing Agreement

    Patient Capital Management, LLC (an investment adviser registered under the Investment Advisers Act of 1940) and Patient Opportunity Trust, hereby agree to file jointly the statement on Schedule 13G to which this Agreement is attached, and any amendments thereto which may be deemed necessary, pursuant to Regulation 13D-G under the Securities Exchange Act of 1934.

    It is understood and agreed that each of the parties hereto is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein, but such party is not responsible for the completeness or accuracy of information concerning the other party unless such party knows or has reason to believe that such information is inaccurate.

    Patient Capital Management, LLC
    Date: February 14, 2024
    Signature: /s/ Milton Dodge
    Name & Title: Milton Dodge, Chief Compliance Officer of Patient Capital Management, LLC

    Patient Opportunity Trust, a series of Advisor Managed Portfolios
    Date: February 14, 2024
    Signature: /s/ Russell B. Simon
    Name & Title: Russell B. Simon, CFO/Treasurer of Advisor Managed Portfolios
    Get the next $GOOS alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $GOOS

    DatePrice TargetRatingAnalyst
    4/30/2025Underweight → Equal Weight
    Wells Fargo
    3/31/2025$10.00 → $8.00Equal Weight → Underweight
    Barclays
    10/21/2024$11.50 → $9.00Neutral → Sell
    Goldman
    10/14/2024Equal Weight → Underweight
    Wells Fargo
    7/23/2024Outperform → Mkt Perform
    Raymond James
    7/19/2024Outperform
    Wedbush
    11/7/2023$11.00In-line
    Evercore ISI
    10/19/2023Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $GOOS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Haider Ackermann Ignites Summer Heat With His Second 'Snow Goose by Canada Goose' Capsule

      The Spring / Summer 2025 Campaign Titled Wild Horizon Propels the Brand into Bold New Territory, Inspiring Exploration of All Kinds Today, Canada Goose unveils the second seasonal capsule from Creative Director Haider Ackermann. Designed under the brand's heritage label, Snow Goose, the capsule launches with a global campaign shot by Willy Vanderperre, for the second season, and features model Lara Stone, alongside a dynamic cast of multidisciplinary talent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612783764/en/ As evident throughout the campaign, Ackermann reimagines the performance legacy of Canada Goose with a mode

      6/12/25 9:30:00 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose Provides Update on Arbitration Proceedings

      Canada Goose Holdings Inc. (NYSE:GOOS, TSX:GOOS) announced today that an arbitrator has awarded financial compensation to a former vendor in connection with a previously announced commercial dispute. The case relates to the termination of a contract in 2021, and the award communicated today has resulted in a one-time financial charge of approximately $30 million USD. Canada Goose disagrees with the legal basis for this award and is assessing available options. This judgment is not related to current vendor relationships or ongoing business operations. Canada Goose maintains strong global partnerships with its vendors and this matter is not expected to have any material impact on the com

      6/4/25 5:00:00 PM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose Announces Participation in the Baird 2025 Global Consumer, Technology and Services Conference

      Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) today announced that it will participate in the Baird 2025 Global Consumer, Technology and Services conference being held at the InterContinental New York Barclay in New York, NY on June 3, 2025. We will host a fireside chat presentation at 3:45 pm ET and participate in one-on-one meetings. Neil Bowden, Chief Financial Officer will attend the conference. The fireside chat presentation will be webcast live on our investor relations website, http://investor.canadagoose.com. An archived webcast will be available after the conclusion of the presentation. About Canada Goose Canada Goose is a performance luxury outerwear, apparel, footwear and ac

      5/30/25 4:00:00 PM ET
      $GOOS
      Apparel
      Consumer Discretionary

    $GOOS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Canada Goose upgraded by Wells Fargo

      Wells Fargo upgraded Canada Goose from Underweight to Equal Weight

      4/30/25 7:23:38 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose downgraded by Barclays with a new price target

      Barclays downgraded Canada Goose from Equal Weight to Underweight and set a new price target of $8.00 from $10.00 previously

      3/31/25 8:11:36 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose downgraded by Goldman with a new price target

      Goldman downgraded Canada Goose from Neutral to Sell and set a new price target of $9.00 from $11.50 previously

      10/21/24 7:42:11 AM ET
      $GOOS
      Apparel
      Consumer Discretionary

    $GOOS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Canada Goose Holdings Inc. Subordinate Voting Shares

      SC 13G/A - Canada Goose Holdings Inc. (0001690511) (Subject)

      11/14/24 12:31:28 PM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Canada Goose Holdings Inc. Subordinate Voting Shares

      SC 13G/A - Canada Goose Holdings Inc. (0001690511) (Subject)

      11/12/24 11:54:03 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Canada Goose Holdings Inc. Subordinate Voting Shares

      SC 13G/A - Canada Goose Holdings Inc. (0001690511) (Subject)

      11/6/24 5:31:25 PM ET
      $GOOS
      Apparel
      Consumer Discretionary

    $GOOS
    SEC Filings

    See more
    • SEC Form 6-K filed by Canada Goose Holdings Inc. Subordinate Voting Shares

      6-K - Canada Goose Holdings Inc. (0001690511) (Filer)

      6/27/25 9:12:23 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • SEC Form SD filed by Canada Goose Holdings Inc. Subordinate Voting Shares

      SD - Canada Goose Holdings Inc. (0001690511) (Filer)

      6/2/25 4:05:33 PM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • SEC Form 6-K filed by Canada Goose Holdings Inc. Subordinate Voting Shares

      6-K - Canada Goose Holdings Inc. (0001690511) (Filer)

      5/21/25 7:46:27 AM ET
      $GOOS
      Apparel
      Consumer Discretionary

    $GOOS
    Leadership Updates

    Live Leadership Updates

    See more
    • Canada Goose Strengthens Executive Team with SVP of Merchandising, Judit Bankus

      Luxury leader to drive long-term merchandising strategy Today, Canada Goose announced Judit Bankus as Senior Vice President of Merchandising. Judit will play a key role in shaping the brand's product roadmap through a lens of sustainability and innovation, to support the company's long-term growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250128073823/en/Judit Bankus (Photo: Business Wire) Reporting to Carrie Baker, President, Brand & Commercial, Judit will oversee the development and execution of global merchandising and pricing strategies, guiding the expansion across both existing and emerging product categories. She

      1/28/25 7:00:00 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose Welcomes Alfredo Cunanan Mendoza Tan as Chief Digital & Information Officer

      Alfredo will oversee all consumer-facing digital platforms, as well as IT, Digital Media & Marketing and Consumer Insights Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) announced today Alfredo C. M. Tan as our new Chief Digital & Information Officer, effective August 7, 2024. Alfredo takes over for Matt Blonder who will be departing Canada Goose. As Chief Digital & Information Officer, Alfredo C. M. Tan will be responsible for the strategy, implementation and adoption of all consumer-facing digital platforms. He will drive the brand's digital capabilities and lead the teams responsible for developing the company's digital roadmap across digital sales channels, as well as the company's IT

      7/12/24 7:00:00 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose Appoints Beth Clymer as President, Finance, Strategy & Administration

      Today, Canada Goose announced the appointment of Beth Clymer to the newly created position of President, Finance, Strategy & Administration, starting January 8, 2024. Beth will oversee Finance, People & Culture, Corporate Strategy and Legal, partnering with the talented leaders who drive these functions. Both Beth and Carrie Baker, President, Brand & Commercial will report to Dani Reiss, Chairman & CEO. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231220857533/en/(Photo: Business Wire) "Beth has a long history and depth of experience working with Canada Goose, having been a key partner of ours during her time at Bain Capital,

      12/20/23 6:45:00 AM ET
      $GOOS
      Apparel
      Consumer Discretionary

    $GOOS
    Financials

    Live finance-specific insights

    See more
    • Canada Goose Reports Fourth Quarter and Full Year Fiscal 2025 Results

      Fourth Quarter Revenue increased 7% year-over-year to $384.6M Reported net income of $27.7M Adjusted EBIT1 of $59.7M Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) announced today financial results for the fourth quarter of fiscal 2025 and fiscal year ending March 30, 2025. All amounts are in Canadian dollars unless otherwise indicated. "Our strong Q4 results show the kind of impact Canada Goose can make when our brand connects and our strategy hits the mark," said Dani Reiss, Chairman and CEO, Canada Goose. "We saw solid DTC comparable sales growth, fuelled by compelling storytelling, sharp retail execution, and the continued momentum around our Snow Goose capsule. As we close out fiscal

      5/21/25 6:45:00 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on May 21, 2025

        Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) plans to announce results for the fourth quarter and fiscal year 2025, which ended March 30, 2025, before markets open on Wednesday, May 21, 2025. The Company will host a conference call and webcast to discuss fourth quarter and fiscal 2025 results at 8:30am ET on Wednesday, May 21, 2025. A live webcast of the conference call will be available on the company's website at http://investor.canadagoose.com. The conference call can be accessed by using the following link: Canada Goose Q4 2025 Earnings Call. After registering, an email including the conference call link will be sent to join the live call. An archived replay of the webcast will be

      5/1/25 7:00:00 AM ET
      $GOOS
      Apparel
      Consumer Discretionary
    • Canada Goose Reports Third Quarter Fiscal 2025 Results

      Revenue of $607.9M Net income attributable to shareholders was $139.7m, or $1.42 per diluted share Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) announced today financial results for the third quarter of fiscal 2025, which ended December 29, 2024. All amounts are in Canadian dollars unless otherwise indicated. "Our third quarter results highlight the power of strong execution during a key consumer shopping period, particularly in December where we saw significant acceleration in the business," said Dani Reiss, Chairman and CEO of Canada Goose. "Brand momentum was robust in the quarter, amplified by the integrated global launch of our new Snow Goose collection which drove record-setting

      2/6/25 6:45:00 AM ET
      $GOOS
      Apparel
      Consumer Discretionary